Overexpression of PAK4 can activate tumor signaling pathways, such as the PI3K/AKT and RAF/MEK/ERK pathways, while low expression of PAK4 can inhibit the growth of ESCC cells. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.